None listed
Conditions
Brief summary
This study is to assess whether serum tryptases released from degranulating mast cells alone, or in combination with other neuron-specific candidates, can serve as a reliable and rapid biomarker for sports related concussion in children. We hypothesis that a rapid increase in serum tryptases released from degranulating mast cells in the brain, alone or in combination with selected neuron-specific proteins, is a reliable indicator of concussion in young people. This study aims to determine whether biomarkers released following a concussion is an accurate tool for the diagnosis and management of sports related concussions.
Interventions
2 groups of participants will be observed. Healthy controls and patient's with a diagnosed sports related concussion/minor traumatic brain injury. Diagnosis will be confirmed by medical specialists through a medical history and examination. Further evaluation will use the Sports Concussion Assessment Tool 5 and other cognitive assessment tools. Concussion may be caused either by a direct blow to the head, face, neck or elsewhere on the body with an impulsive force transmitted to the head. Concussion typically results in the rapid onset of short-lived impairment of neurological function that resolves spontaneously. However, in some cases, signs and symptoms evolve over a number of minutes to hours. Concussion may result in neuropathological changes, but the acute clinical signs and symptoms largely reflect a functional disturbance rather than a structural injury and, as such, it is currently thought that no abnormality is seen on standard structural neuro-imaging studies. Concussion results in a range of clinical signs and symptoms that may or may not involve loss of consciousness. Resolution of the clinical and cognitive features typically follows a sequential course. However, in some cases symptoms may be prolonged. We will observe patients diagnosed with a concussion for a total of 28 days, over which time participants will undergo clinical evaluation, cognitive testing and exercise testing, in addition to measurement of serum biomarkers. Healthy participants will have a single measurement of the biomarkers to determine normative values for non-concussed, age matched participants.
Sponsors
Eligibility
Inclusion criteria
Males and females between the ages of 10-18 years participating in high-contact (impact) sports (patients) and age and sex matched young people not involved in high-contact (impact) sports (controls).
Exclusion criteria
Potential participants with acute exacerbation of allergic inflammation including but not restricted to asthma, eczema, food allergy or anaphylaxis, individuals with recent head injury (<6 months), existing neurological or non-neurological chronic diseases, recent major surgery or those who suffered multiple injuries in the current incident will be excluded.